ACE2 and COVID-19: Endothelial dysfunction has been reported as a main physiopathological feature in COVID-19, revealed by different histopathological studies [44, 45] and partially explained by the high endothelial expression of angiotensin converting enzyme 2, the SARS-CoV-2 receptor [46].